US SB1532 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on May 16 2019 - 25% progression, died in committee
Action: 2019-05-16 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 16 2019 - 25% progression, died in committee
Action: 2019-05-16 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
Title
Pharmacy Benefit Manager Accountability Study Act of 2019
Sponsors
Sen. Marsha Blackburn [R-TN] | Sen. Mike Braun [R-IN] |
History
Date | Chamber | Action |
---|---|---|
2019-05-16 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
Congressional oversight
Drug therapy
Government employee pay, benefits, personnel management
Government studies and investigations
Health
Health care costs and insurance
Inflation and prices
Medicaid
Medicare
Prescription drugs
Drug therapy
Government employee pay, benefits, personnel management
Government studies and investigations
Health
Health care costs and insurance
Inflation and prices
Medicaid
Medicare
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1532/all-info |
Text | https://www.congress.gov/116/bills/s1532/BILLS-116s1532is.pdf |